Abstract
Targeted drug delivery to peripheral blood neutrophils (PMNs) should be of therapeutic potential in various disease states. In addition, substances taken up by PMNs in the circulation may be delivered to an extravascular site via the naturally occurring cell infiltration. The present study employs an in vitro chemotaxis model to test whether particulate drug carriers such as liposomes can be transported across a cellular barrier by migrating PMNs. The system contained 107 human PMNs/ml, 0.3-µm liposomes at a total lipid concentration of 2.5 mM, and 10% autologous human serum in the apical side of a confluent Madin Darby canine kidney (MDCK) epithelial cell monolayer of 4.71 cm2. The MDCK cells were grown on a polycarbonate membrane with 3-µm pores without any extracellular matrix, and 10−7 M f-Met-Leu-Phe was added to the basolateral side as a trigger of chemotaxis. The aqueous phase of the reverse-phase evaporation vesicles (REVs) contained lucifer yellow CH (LY) and [14C]sucrose. The lipid bilayer of the REVs was spiked with [3H]dipalmitoylphosphatidylcholine (DPPC). Transmission electron micrographs showed that, in response to the formyl peptide, PMNs adhered to the apical surface of MDCK cells, emigrated across the MDCK cell layer, passed through the 3-µm pores in the polycarbonate membrane, and finally, appeared in the bottom well. Epifluorescence micrographs showed that most, if not all, of the migrated PMNs contained punctate fluorescence derived from LY. Transport data over a 3.5-hr period indicated that those markers that appeared in the basal side were indeed transported by phagocytosis of REVs by PMNs and that intact serum was an essential component in the process. The PMN-mediated transport of REVs may serve as a possible targeted drug delivery to an extravascular site in vivo in various inflammatory diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
J. M. Harlan. Blood 65:513–525 (1985).
J. F. Scieszka and M. J. Cho. Pharm Res. 5:352–358 (1988).
A. W. Segal. In G. Gregoriadis (ed.), Drug Carriers in Biology and Medicine, Academic Press, New York, 1979, pp. 155–165 (and references therein).
G. Poste, C. Bucana, A. Raz, P. Bugelski, R. Kirsh, and I. J. Fidler. Cancer Res. 42:1412–1422 (1982).
E. B. Cramer, L. C. Milks, M. J. Brontoli, G. K. Ojakian, S. D. Wright, and H. J. Showell. J. Cell Biol. 102:1868–1877 (1986).
M. J. Cho, D. P. Thompson, C. T. Cramer, T. J. Vidmar, and J. F. Scieszka. Pharm. Res. 6:71–77 (1989).
A. Boyum. Scand. J. Clin. Lab. Invest. 21(Suppl. 97):77–89 (1968).
F. Szoka and D. Papahadjopoulos. Proc. Natl. Acad. Sci. USA 75:4194–4198 (1978).
E. S. Reynolds. J. Cell Biol. 17:208–212 (1963).
I. G. Colditz. In H. Z. Movat (ed.), Leukocyte Emigration and Its Sequelae, Karger AG, Basel, Switzerland, 1987, pp. 14–23.
L. C. Milks, M. J. Brontoli, and E. B. Cramer. J. Cell Biol. 96:1241–1247 (1983).
A. Thureson-Klein, P. Hedqvist, and L. Lindbom. Tissue Cell 18:1–12 (1986).
R. E. Lewis and H. J. Granger. Fed. Proc. 45:109–113 (1986).
E. Svensjo and G. J. Grega. Fed. Proc. 45:89–95 (1986).
J. H. Senior. CRC Crit. Rev. Ther. Drug Carrier Syst. 3:123–193 (1987).
J. Crawford, H. J. Movat, N. S. Ranadive, and J. B. Hay. Fed. Proc. 41:2583–2587 (1982).
R. Vinegar, J. F. Truax, J. L. Selph, and F. A. Voelker. Fed. Proc. 41:2588–2595 (1982).
G. Poste. Biol. Cell 47:19–38 (1983).
J. M. Besterman and R. B. Low. Biochem J. 210:1–13 (1983).
R. M. Steinman, I. S. Mellman, W. A. Muller, and Z. A. Cohn. J. Cell Biol. 96: 1–27 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cho, M.J., Scieszka, J.F., Cramer, C.T. et al. Neutrophil-Mediated Transport of Liposomes Across the Madin Darby Canine Kidney Epithelial Cell Monolayer. Pharm Res 6, 78–84 (1989). https://doi.org/10.1023/A:1015859921397
Issue Date:
DOI: https://doi.org/10.1023/A:1015859921397